Olivier Saidi

Prior to joining M.M. Dillon & Co. in 2009, which was also previously known as CRT Investment Banking, Olivier served as a Managing Director at CRT Capital Group. Prior to joining CRT Capital Group, Olivier was the founder and CEO of 5 Gems Strategic Advisory. In 2001, he co-founded and served as Co-founder and CTO of Aureon Biosciences, a service laboratory in the space of predictive and personalized cancer focused clinical diagnostics and prognostics.